Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edwards SAPIEN 3 Transcatheter Heart Valve Therapy for High Risk and Inoperable Patients

NCT03222141 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03222141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03222141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edwards SAPIEN 3 Transcatheter Heart Valve Therapy for High Risk and Inoperable Patients
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2013
Completion date
August 31, 2020
Enrollment
583 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic severe aortic stenosis